Target intelligence / Profile preview

RALBP1 pseudogene 2 (RALBP1P2)

Target
RALBP1P2
Molecular classification
Other (pseudogene)
01

Overview

RALBP1 pseudogene 2 (RALBP1P2) is a non-coding pseudogene homologous to the RalA-binding protein 1 gene (RALBP1). Pseudogenes are DNA segments resembling functional genes but lack coding or regulatory capacity to produce proteins. As a pseudogene, RALBP1P2 does not have characterized molecular functions, disease roles, or interactions typical of therapeutic targets. Its sequence similarity to RALBP1 might allow it to participate in regulatory RNA interactions, such as competing for RNA binding proteins or modulating the stability of parental gene transcripts, but any biological effects are hypothetical and not established as therapeutic mechanisms. In contrast, RALBP1 is a multifunctional protein involved in receptor-mediated endocytosis, cell migration, and drug resistance, and is considered a potential therapeutic target in some cancers. If you are seeking structured data for an actionable therapeutic target, RALBP1 pseudogene 2 (RALBP1P2) is not suitable; the canonical entity is RalA-binding protein 1 (RALBP1).

02

Mechanism of action

None for RALBP1P2. RALBP1 acts as a transporter and efflux pump for certain drugs, but the pseudogene has no protein product or known mechanism of drug interaction.

03

Biological functions

None directly for RALBP1P2. Pseudogenes may affect gene regulation by sequence competition or RNA interaction but do not encode functional proteins.
04

Disease associations

None directly for RALBP1P2. The parent gene RALBP1 is linked to cancer, particularly lung, prostate, and bladder cancer; however, roles for the pseudogene are unknown.

Beyond the preview

Go deeper on RALBP1 pseudogene 2 (RALBP1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RALBP1 pseudogene 2 (RALBP1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call